Page last updated: 2024-09-05

succinobucol and elsibucol

succinobucol has been researched along with elsibucol in 1 studies

Compound Research Comparison

Studies
(succinobucol)
Trials
(succinobucol)
Recent Studies (post-2010)
(succinobucol)
Studies
(elsibucol)
Trials
(elsibucol)
Recent Studies (post-2010) (elsibucol)
53516501

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, RR; Hoong, LK; Hotema, MR; Howard, RB; Kunsch, C; Landers, LK; Luchoomun, J; MacDOnald, ML; Marino, EM; Meng, CQ; Saxena, U; Sikorski, JA; Simpson, JE; Somers, PK; Stefanopoulos, D; Suen, KL; Sundell, CL; Wasserman, MA; Weingarten, MD; Worsencroft, KJ; Ye, Z; Zheng, XS1

Other Studies

1 other study(ies) available for succinobucol and elsibucol

ArticleYear
Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.
    Journal of medicinal chemistry, 2004, Dec-02, Volume: 47, Issue:25

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antioxidants; Cells, Cultured; Cholesterol, HDL; Cholesterol, LDL; Chronic Disease; Cricetinae; Depression, Chemical; Endothelial Cells; Endothelium, Vascular; Humans; Inflammation; Interleukin-1; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Phenols; Probucol; Structure-Activity Relationship; Sulfides; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1

2004